Holen Sie sich die Stockscreener-App
76.22
0.25%
-0.615
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Disc Medicine at cantorfitzgerald healthcare conference: pipeline nears key tests - Investing.com Canada
Disc Medicine faces class action over alleged m... - Pluang
Legal & General Group Plc Invests $1.35 Million in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Small Disc Medicine (NASDAQ: IRON) shareholder sale planned - Stock Titan
Disc Medicine (NASDAQ: IRON) files notice to sell about $60K in stock - Stock Titan
Disc Medicine (NASDAQ: IRON) holder plans $72K stock sale - Stock Titan
Proposed $176K Disc Medicine (NASDAQ: IRON) share sale by Atlas Venture Fund X - Stock Titan
Kevin Bitterman Sells 129 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Insider Selling: Disc Medicine (NASDAQ:IRON) Director Sells $3,941,477.88 in Stock - MarketBeat
Kevin Bitterman Sells 5,203 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine (IRON) director's funds sell 54K shares in 10b5-1 trades - Stock Titan
Disc Medicine(IRON.US) Director Sells US$4.37 Million in Common Stock - Moomoo
Atlas fund plans small Disc Medicine (NASDAQ: IRON) share sale - Stock Titan
Venture fund plans Disc Medicine (IRON) share sale - Stock Titan
Disc Medicine (NASDAQ: IRON) investor plans $225K stock sale - Stock Titan
Disc Medicine (IRON) investor plans 2,339-share sale - Stock Titan
Man Group plc Takes $1.09 Million Position in Disc Medicine, Inc. $IRON - MarketBeat
The Manufacturers Life Insurance Company Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
Venture fund to sell 513 Disc Medicine (NASDAQ: IRON) shares - Stock Titan
Disc Medicine (NASDAQ: IRON) investor plans Rule 144 share sale - Stock Titan
Venture backer plans Disc Medicine (NASDAQ: IRON) share sale - Stock Titan
Venture fund plans Disc Medicine (IRON) share resale - Stock Titan
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - Stocktwits
IRON Maintained by Wedbush -- Price Target Raised to $100 - GuruFocus
Disc Medicine (NASDAQ:IRON) Price Target Raised to $100.00 at Wedbush - MarketBeat
Disc Medicine to Participate in Upcoming Investor Conferences - The Manila Times
Four live webcasts are planned for September, with replays after each - Stock Titan
Bank of New York Mellon Corp Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire
Cantor Fitzgerald reiterates Disc Medicine stock rating on survey data By Investing.com - Investing.com Nigeria
Cantor Fitzgerald reiterates Disc Medicine stock rating on survey data - Investing.com
Disc Medicine faces class action after FDA reje... - Pluang
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - prnewswire.com
Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting - The Manila Times
Disc Medicine to Present RESTORE-PV and RALLY-MF Data at SOHO Annual Meeting - Quiver Quantitative
Disc Medicine (NASDAQ:IRON) Cut to "Sell" at Wall Street Zen - MarketBeat
Disc Medicine (IRON) Faces Legal Scrutiny, Is The Stock Still Cheap? - Sahm
Deutsche Bank AG Acquires New Holdings in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine (IRON): Betting On Iron And Heme Biology - RTTNews
Disc Medicine, Inc. (NASDAQ:IRON) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Disc medicine COO Yu sells $755,851 in shares By Investing.com - Investing.com South Africa
Disc Medicine (NASDAQ:IRON) COO Jonathan Yen-Wen Yu Sells 8,796 Shares - MarketBeat
Disc Medicine (NASDAQ:IRON) COO Sells $24,759.00 in Stock - marketbeat.com
Disc Medicine (IRON) COO sells 9,096 shares at ~$83 - Stock Titan
Disc medicine COO Yu sells $755,851 in shares - Investing.com
Disc Medicine faces class action over FDA rejec... - Pluang
Will FDA Bitopertin Rejection and New Legal Probe Change Disc Medicine's (IRON) Narrative? - Sahm
Disc (IRON) Quarterly Figures: EPS Exceeds Its Estimate for the Current Session; Price Reaction: Shares Move 1.84% Lower in the Available RecordQuarterly Earnings - vinanet.vn
Rosen Law Firm investigates Disc Medicine over potential securities claims - scanx.trade
Handelsbanken Fonder AB Buys Shares of 12,700 Disc Medicine, Inc. $IRON - MarketBeat
Disc (IRON) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Trading Move - vinanet.vn
Disc Medicine CEO John Quisel sells $2.6m in shares By Investing.com - Investing.com Australia
Disc Medicine CEO John Quisel sells $2.6m in shares - Investing.com
Disc Medicine CEO John D. Quisel disposes of USD 2.63 million in common shares - Bitget
Insider Selling: Disc Medicine (NASDAQ:IRON) CEO Sells 33,000 Shares of Stock - MarketBeat
Disc Medicine (IRON) CEO sells 33K shares under trading plan - Stock Titan
GSA Capital Partners LLP Takes $1.19 Million Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine (NASDAQ: IRON) insider to sell 33,000 shares via plan - Stock Titan
Disc Medicine (IRON) Pulls Back 1.46% to $78.84 as Shares Test Key Resistance ZoneExhaustion Gap - vinanet.vn
Disc Medicine (IRON) Slips 1.46% as Biotech Consolidates Near Key SupportCovered Call ETF - vinanet.vn
Disc Medicine COO Jonathan Yu sells $66,444 in shares By Investing.com - Investing.com Australia
0.63%
3.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):